Bioten Co., Ltd Logo

Bioten Co., Ltd

Develops biotech health supplements, animal feed additives, and functional cosmetics.

289170 | KO

Overview

Corporate Details

ISIN(s):
KR7289170003
LEI:
Country:
South Korea
Address:
전북특별자치도 정읍시 첨단2로 64 -, 정읍시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Bioten Co., Ltd. is a biotechnology company engaged in the development, manufacturing, and sale of health supplements, animal feed additives, and functional cosmetics. Established in 2011, the company focuses on commercializing scientific research and technology. Its product line includes health-functional foods such as probiotics, collagen, and a proprietary solubilized curcumin designed for enhanced absorption and immune support. The company also develops animal feed additives and explores therapeutic treatments through its drug pipeline research.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-13 00:00
Regulatory Filings
본점소재지변경
Korean 5.1 KB
2025-07-17 00:00
Regulatory Filings
[기재정정]신규시설투자등
Korean 13.2 KB
2025-06-26 00:00
Regulatory Filings
기업설명회(IR)개최결과
Korean 6.9 KB
2025-04-16 00:00
Regulatory Filings
신규시설투자등
Korean 7.9 KB
2025-03-26 00:00
AGM Information
정기주주총회결과
Korean 25.4 KB
2025-03-26 00:00
Board/Management Information
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Korean 9.7 KB
2025-03-18 00:00
Audit Report / Information
감사보고서제출
Korean 9.6 KB
2025-03-18 00:00
Annual Report
사업보고서 (2024.12)
Korean 808.5 KB
2025-03-14 00:00
Board/Management Information
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Korean 9.7 KB
2025-03-11 00:00
Pre-Annual General Meeting Information
주주총회소집결의
Korean 14.7 KB
2025-03-11 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 155.9 KB
2025-02-18 00:00
M&A Activity
주요사항보고서(유형자산양도결정)
Korean 15.2 KB
2024-12-13 00:00
Pre-Annual General Meeting Information
주주명부폐쇄기간또는기준일설정
Korean 4.2 KB
2024-11-19 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 74.5 KB
2024-11-19 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 22.4 KB

Automate Your Workflow. Get a real-time feed of all Bioten Co., Ltd filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Bioten Co., Ltd

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Bioten Co., Ltd via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

INSMED Inc Logo
Develops and commercializes innovative therapies for serious and rare diseases.
United States of America
INSM
Instil Bio, Inc. Logo
Developing autologous TIL cell therapies using a patient's own immune cells to fight solid tumors.
United States of America
TIL
INTENSITY THERAPEUTICS, INC. Logo
Develops injected therapies to kill tumors locally and activate a systemic immune response.
United States of America
INTS
Intercure Ltd. Logo
Develops and distributes pharmaceutical-grade medical cannabis for patients and pharmacies globally.
Israel
INCR
Intervacc AB Logo
Develops recombinant protein vaccines and diagnostics for animal health, like Strangvac® for horses.
Sweden
IVACC
iNtRON Biotechnology, Inc. Logo
Develops phage therapeutics and molecular diagnostics to combat infectious diseases.
South Korea
048530
Inventiva Logo
Clinical-stage biopharma developing oral therapies for fibrosis, oncology, & lysosomal disorders.
France
IVA
Inventiva S.A. Logo
Develops oral small molecule therapies for NASH, fibrosis, and rare metabolic disorders.
United States of America
IVA
Invivyd, Inc. Logo
Develops evolution-resistant antibodies to protect against viral diseases like COVID-19 and flu.
United States of America
IVVD
IO Biotech, Inc. Logo
Develops dual-action, off-the-shelf therapeutic cancer vaccines for solid tumors.
United States of America
IOBT

Talk to a Data Expert

Have a question? We'll get back to you promptly.